← FDA DRUG APPROVALS

FDA NDA · NDA018000

BRICANYL

Sponsor: SANOFI AVENTIS US

APPLICATION
NDA018000
TYPE
NDA
ORIGINAL APPROVAL
1985-03-19
LATEST ACTION
1985-03-19
ROUTE
INHALATION
DOSAGE FORM
AEROSOL, METERED
MARKETING STATUS
Discontinued

Products

BRICANYLDiscontinued
TERBUTALINE SULFATE 0.2MG/INH · AEROSOL, METERED · INHALATION

Approval history

1985-03-19Type 3 - New Dosage Form · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →